Tennessee Comprehensive Lung and Sleep Center offers a gateway to the frontiers of research and development in the field of pulmonary medicine.  Pharmaceutical companies ask our physicians to serve as primary investigators for their studies in the development of treatments for diseases like asthma and COPD.  Within the framework of our center, we have a research team that allows us to screen patients for immediate consideration in new and innovative therapeutic studies.

If you are interested in participating in one of our research studies, please contact our clinical research department at:

Dr. Clyde Southwell, MD, FCCP.
Email: Admin@lungandsleeptn.com or Phone: (615) 822-2214

Currently Enrolling Clinical Trials at TCLS:
Oncocyte (Pulmonary Nodules)
A study to evaluate a panel of blood biomarkers for use in patients undergoing evaluation for lung cancer.
This is a post-marketing observational study comparing the cardiovascular and cerebrovascular events in COPD patients using Anoro, Incuse or Spiriva.
PT010005 (COPD):

A study to evaluate COPD exacerbations over a 52-week treatment period in patients with moderate to very severe COPD.

PT001102 (Asthma):

A study to compare the efficacy and safety of drug to Spiriva in patients with persistent asthma.

Navigator (Asthma):

A study to evaluate the efficacy and safety of drug in adults and adolescents with severe, uncontrolled asthma.

Captain (Asthma):

A study to evaluate the effects of asthma patients receiving triple therapy through a single inhaler.

Chronicle (Asthma):

Observational study of the characteristics, treatment patterns and health outcomes of individuals with severe asthma in the United States.